echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > At the end of the year, the "personnel earthquake" in the medical circle continued, and many senior managers changed!

    At the end of the year, the "personnel earthquake" in the medical circle continued, and many senior managers changed!

    • Last Update: 2019-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends] the end of the year is a period of frequent personnel changes in all walks of life, especially for the pharmaceutical industry which has been greatly changed this year Under the background of the changing pattern of the pharmaceutical industry, the industry is also accompanied by the adjustment of enterprise talents in the process of transformation The author found that since December, the "personnel earthquake" in the medical circle has continued, and many executives have resigned or replaced Kelun pharmaceutical: the resignation of senior executives on December 23, Kelun pharmaceutical announced that the board of directors of the company received the resignation report from Mr Deng Xuheng, deputy general manager of the company on December 20, 2019 Mr Deng Xuheng resigned from the post of deputy general manager of the company due to the independent development of Ili CHUANNING Biotechnology Co., Ltd., a subsidiary of Kelun pharmaceutical Mr Deng Xuheng will continue to be executive director and general manager of CHUANNING biology after resigning from the post of deputy general manager of the company Jichuan Pharmaceutical Co., Ltd.: Deputy General Manager resigns and general manager changes On December 21, Jichuan pharmaceutical announced that the board of directors of the company recently received written resignation letters from Mr Cao Longxiang, chairman and general manager of the company, and Mr Huang qurong, vice chairman and executive deputy general manager Due to work adjustment, Mr Cao Longxiang no longer holds the post of general manager of the company and resigns from relevant positions of remuneration and assessment committee and Nomination Committee of the board of directors, and continues to serve as the chairman of the company and members of the strategy committee of the board of directors after resigning; Mr Huang qurong no longer holds the post of executive deputy general manager of the company, and continues to serve as the vice chairman, strategy committee and Audit Committee of the board of directors Council member At the same time, upon nomination of the chairman of the board of directors and approval of the nomination committee of the board of directors, Cao Fei was appointed as the general manager of the company Hua Ren pharmaceutical: senior executives and securities representatives resigned On December 19, Hua Ren pharmaceutical announced that the company recently received a written resignation report from Mr Ji Shengbin, vice president of the company, and Ms Cai Yanyan, securities representative Mr Ji Shengbin applied for resigning from the position of vice president of the company for personal reasons and no longer holding other positions in the company Ms Cai Yanyan applied for resigning from the position of securities affairs representative of the company and no longer holding other positions in the company due to personal reasons Kyrgyz Holdings: Secretary of the board of directors resigned on December 16, Kyrgyz holdings announced that the board of directors of the company recently received a written resignation report submitted by Mr Zhang Liang, Secretary of the board of directors Mr Zhang Liang resigned as secretary of the board of directors for personal reasons After resigning as secretary of the board of directors, Mr Zhang Liang will continue to be a director and deputy general manager of the company Harbin Pharmaceutical Co., Ltd.: resignation of senior executives on December 13, Harbin Pharmaceutical Co., Ltd announced that the board of directors of the company received the resignation report of Mr Zhou Xing, deputy general manager of the company, and Mr Zhou Xing resigned from the position of deputy general manager of the company due to personal reasons Northeast Pharmaceutical: securities affairs representative resigns December 11, Northeast Pharmaceutical announced that the board of directors of the company recently received a written resignation report from Ms Tian Fang, securities affairs representative of the company Ms Tian Fang applied to resign as a representative of the company's securities affairs due to work adjustment, and the resignation application shall take effect from the date when it is delivered to the board of directors Dong'a-jiao: the change of the chairman of the board of directors: on December 10, dong'a-jiao announced that Han Yuewei was elected as the chairman of the ninth board of directors at the 10th meeting of the ninth board of directors On November 14, dong'a-jiao announced that the board of directors of the company had received the written resignation report from Wang Chuncheng, the chairman of the board of directors of the company Wang Chuncheng applied to resign from the position of chairman and director of the ninth board of directors of the company, as well as the position of chairman of the strategic committee of the ninth board of directors of the company After resigning, Wang Chuncheng no longer holds any position in the company Jinshiya Pharmaceutical Co., Ltd.: on December 9, jinshiya pharmaceutical announced that the company had recently received the resignation report from general manager Kuai Yixi Mr Kuai Yixi applied to resign from the position of general manager of the company After resigning, he still served as chairman of the company, chairman of the remuneration and assessment committee of the board of directors, chairman of the strategy and investment decision-making committee of the board of directors and chairman of the nomination committee of the board of directors At the same time, upon the recommendation and review of the nomination committee of the third board of directors, it is agreed to submit the appointment of Mr Wei Baokang as the general manager of the company to the board of directors for deliberation Wohua pharmaceutical: change of President on December 6, wohua pharmaceutical announced that the company recently received a written resignation report from President Li Shengting, who applied to resign as president of the company due to work adjustment At the same time, upon nomination of the chairman of the board of directors, the qualification examination of the nomination committee of the sixth board of directors was passed, and the board of directors agreed to appoint Ms Zeng yingzi, the former vice president of the company, as the president of the company for the same term as the current board of directors.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.